Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidChannelview Pharmacy
    Ask Trek AI about this page

    Channelview Pharmacy — Billing Profile & Reimbursement Data

    NPI 1063515195 · XX · healthcare

    Customize your policy alerts

    Sign up for Channelview Pharmacy — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Channelview Pharmacy is a healthcare provider located in Unspecified Location. This profile covers 1 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services. Note: "XX" is a placeholder CMS uses when a provider's practice-location state wasn't reported — not a traditional US state; claims coded under it are grouped and benchmarked here the same way a traditional state would be.

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationChannelview Pharmacy
    Address
    City
    StateXX (Unspecified Location)
    ZIP
    TaxonomyN/A
    NPI Enumerated
    NPI DeactivatedNovember 13, 2023

    (source: CMS Medicare & Medicaid claims data)

    Key Findings

    CHANNELVIEW PHARMACY reports $7.6M in lifetime Medicare revenue and has no Medicaid billing on file, making its public payer footprint effectively single-payer at the time of these records. The absence of any Medicaid claims means cross‑payer comparisons and in‑state competitive positioning against Medicaid activity cannot be assessed from available data.

    Revenue concentration is extreme: K1034 (provision of covid-19 test, nonprescription self-administered and self-collected use) accounts for $7.6M in Medicare revenue and is reported as 100.0% of this provider's total Medicare revenue; the precomputed summary also notes the top three Medicare codes together account for 100.0% of Medicare revenue. This indicates virtually all reported Medicare billing is driven by a single HCPCS product line.

    The code-level volume is unusually large for a single provider: K1034 is listed with 635.8K claims and a $12 avg paid/claim, producing the $7.6M revenue figure. That mix — very high claim count with a low per-claim payment — is consistent with high-throughput retail distribution of over‑the‑counter items rather than episodic clinical services.

    Service-line implications: ’s description (nonprescription, self‑administered COVID-19 test, FDA approved/authorized/cleared) indicates this entity functions primarily as a dispenser or distributor of OTC COVID-19 tests to Medicare beneficiaries. The billing profile suggests a transactional, product-distribution business model rather than a medical practice providing in‑person clinical care.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare Revenue by CPT/HCPCS Code

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    1 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    K1034Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count635,760$10$7.6M

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes. Note: this provider's state, "XX," is a placeholder CMS uses when a provider's practice-location state wasn't reported — not a traditional US state; the State panel below benchmarks against other providers coded under the same designation.

    View: State1 / 2

    Claims Volume vs. Unspecified Location Distribution
    Channelview Pharmacy — 0 of 0 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Unspecified Location

    Full comparison — all codes billed, vs. state median

    1 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    K1034110N/A$N/A$N/A

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    Lifetime revenue by payer source
    Payer SourceTotal Paid
    Medicare$7.6M
    Medicaid$0
    K1034

    Competitive standing on Medicare for this code is exceptional: the provider ranks #66 of 30143 nationally and is characterized as an "extreme outlier, far above typical national volume for this code". That percentile/rank signals national-scale activity for K1034, positioning the provider well above typical peers on that single product line.

    Business and operational implications: dependence on one code (and effectively on a single payer) concentrates revenue exposure — changes in reimbursement policy, product eligibility, or beneficiary demand for K1034 would materially affect reported Medicare revenue. Analysts should treat future revenue projections and comparatives with caution given this lack of diversification.

    Operational profile inference: the combination of very high claim volume (635.8K) and modest average payment ($12 per claim) implies a high-throughput logistics and retail dispensing operation with large unit volumes but thin per-item margins. This profile has implications for inventory, supply chain, and reimbursement monitoring priorities.

    Data limitations constrain some routine analyses: city, state, provider taxonomy, and NPI enumeration are listed as unknown, so tenure, local market share, and in‑state competitive comparisons cannot be determined from the provided data. Any regional or ownership inferences should be deferred until supplementary enrollment and location records are available.